Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Neuroendocrine Tumors: Management and Updates

Integrity CE

R. Iyer

Neuroendocrine Tumors in the GI Tract

Florida Gastroenterologic Society

A. Luthra

Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Total Health

A. Grothey

Neuroendocrine Cancers: Background, Diagnosis, and Current Treatment

Total Health

R. Lentz

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

Imaging for Neuroendocrine Neoplasms

North American Neuroendocrine Tumor Society

G. Spilberg

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Horizon CME

A. Scott

NETs 101 and Overview of Medical Management

Yale Cancer Center

P. Kunz

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

New Developments in Neuroendocrine Tumor Treatment

Oncology Data Advisor

S. Kareff, A. Chauhan

Debates in NET Treatment: Surgery vs. IR for Liver-Limited Disease

Integrity CE

E. Liu

Medical Oncology Updates in NETs

2023 Johns Hopkins Updates in Gastrointestinal Cancers

P. Kunz

Role of Precision Medicine in the Treatment of Neuroendocrine Neopla…

University of Miami Sylvester Comprehensive Cancer Center

A. Chauhan

Metastatic Grade 2 NET: Case Presentation and Panel Discussion

Integrity CE

A. De Jesus-Acosta, L. Bjork Solnes, J. Strosberg, E. Liu, R. Lidell

How the Experts Manage: Cardiotoxicity and IO in NSCLC

MI&T Congressi

J. Remon Masip

ACC 2024 Insights: Pearls of Cardio-Oncology Screening and Management

ACC 2024 Insights

J. Johnson

Management of Poorly Differentiated Neuroendocrine Carcinomas

North American Neuroendocrine Tumor Society

J. Chan